Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q3 2017 · 10-Q
Revenue$227.84M$227.84M−2.4% vs Q3 2016 Net Income$15.39M$15.39MN/M vs Q3 2016 EPS Diluted$0.30$0.30N/M vs Q3 2016 Gross Profit$101,079,000−7.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$55,201,000+73.3% Free Cash Flowderived$36,308,000+347.7% Margins · derivedGross margin44.4%−2.3 pt vs Q3 2016
Operating margin9.3%+35.5 pt vs Q3 2016
Net margin6.8%+32.2 pt vs Q3 2016
ended Dec 31, 2016 · filed Feb 6, 2017 · 37 d after period end